News Sentiment

CARL sentiment intelligence

Carlsmed, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 11.90 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 63

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

+4.9% over one week, +4.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 4.9% Price confirming higher
Trend fit Trend inactive 4.2% over four weeks
Fair value -3.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 49
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 63
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 21
Stock Titan 8
Market source 5
Finviz 3
Moomoo 2
Zacks 2
Investing.com 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 17
Balance sheet 5
Analyst action 4
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
富途牛牛 Direct company coverage

Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m

The article discusses the investment performance of insiders at Carlsmed, noting a collective loss of US$1.7 million despite a recent positive stock performance. It highlights that insiders bought shares at an average price of US$13.43 and the current price is US$3.88, indicating

Tone
Positive 59/100
Event
Market update
Published
07 Jul 2026 02:39
Source
富途牛牛
Finviz Direct company coverage

CARL - Carlsmed Inc Revenue Breakdown

This article provides a detailed financial breakdown of Carlsmed Inc. (CARL), including its latest stock performance, market capitalization, revenue, income, and various financial ratios. It also lists insider and institutional ownership, analyst recommendations, and key performa

Tone
Positive 61/100
Event
Earnings
Published
01 Jul 2026 23:10
Source
Finviz
Simply Wall Street Direct company coverage

Carlsmed (NasdaqGS:CARL) Stock Forecast & Analyst Predictions

Carlsmed (NasdaqGS:CARL) is forecasted to increase earnings by 2.2% and revenue by 33.7% per annum. The company has raised its earnings guidance multiple times for both 2025 and 2026, anticipating significant revenue growth. Recent updates include reporting higher-than-expected Q

Tone
Positive 64/100
Event
Earnings
Published
01 Jul 2026 12:12
Source
Simply Wall Street
TradingView Direct company coverage

CARL Forecast — Price Target — Prediction for 2027

This article provides a forecast for Carlsmed, Inc. (CARL) stock, including analyst price targets, historical performance, earnings information, and financial data. Five analysts offer a 1-year price forecast, with current stock performance showing recent increases but a year-ove

Tone
Positive 59/100
Event
Analyst action
Published
27 Jun 2026 00:09
Source
TradingView
TradingView Direct company coverage

Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL)

Carlsmed, Inc. (NASDAQ:CARL) stock is currently trading at $11.76, having shown recent fluctuations with a weekly rise of 13.54% and a monthly fall of 3.45%. Analysts forecast a price range between $16.00 and $23.00, and the company is expected to report earnings on August 27, 20

Tone
Positive 65/100
Event
Earnings
Published
26 Jun 2026 21:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Carlsmed, Inc. – NASDAQ:CARL

This article provides key financial information for Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its enterprise value to forward revenue. It highlights the company's stock market presence on Nasdaq and offers an overview of its financials, news, and community data thro

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 20:39
Source
TradingView
TradingView Direct company coverage

Carlsmed, Inc. Actuals & Estimates (DUS:I82)

This article provides an overview of Carlsmed, Inc. (DUS:I82) stock, including its financial actuals and estimates. It covers details like analyst forecasts, historical price performance, upcoming earnings dates, and key financial metrics such as revenue, net income, and EBITDA.

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 15:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Carlsmed, Inc. – NASDAQ:CARL

This article provides a financial snapshot of Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication, with no trades occurring. The content is primarily a data placeholder from T

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 08:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Carlsmed, Inc. – LSX:A41CM7

This article provides a brief financial overview of Carlsmed, Inc. (LSX:A41CM7) focusing on its enterprise value to revenue forward metric. The information is presented within the TradingView platform, noting that the market is currently closed.

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 08:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Carlsmed, Inc. – LSX:A41CM7

This page provides financial data, specifically the Enterprise Value to EBITDA forward, for Carlsmed, Inc. (A41CM7) traded on the Lang & Schwarz Exchange. The content is primarily a data page from TradingView, offering an overview of the company's financial performance.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 07:40
Source
TradingView
TradingView Direct company coverage

Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7)

This article provides an overview of Carlsmed, Inc. (LSX: A41CM7) focusing on its financial actuals, estimates, and stock performance. It includes details such as the current stock price, market capitalization, volatility, revenue, earnings, and analyst forecasts for its future p

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 15:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Carlsmed, Inc. – LSX:A41CM7

This article provides the "Price to earnings forward" value for Carlsmed, Inc. (LSX:A41CM7) on the Lang & Schwarz Exchange. It indicates that the market is currently closed with no trades. The article also includes general information about TradingView's platform and its various

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 12:10
Source
TradingView
Moomoo Direct company coverage

BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23

BTIG has reiterated its Buy rating on Carlsmed (CARL.US) and maintained its price target of $23. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Tone
Positive 75/100
Event
Analyst action
Published
24 Jun 2026 21:09
Source
Moomoo
Stock Titan Direct company coverage

[Form 4] CARLSMED, INC. Insider Trading Activity

CARLSMED, INC. director Kevin C. O’Boyle was granted 13,698 shares of Common Stock as a stock award with no cash price per share. Following this transaction, he directly holds 31,031 common shares. These restricted stock units (RSUs) vest in full on the earlier of the day before

Tone
Neutral 50/100
Event
Balance sheet
Published
22 Jun 2026 14:12
Source
Stock Titan
TradingKey Direct company coverage

Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Carlsmed Ord Shs (CARL), detailing analyst ratings and growth estimates. Based on 5 analysts, the stock has a "Buy" rating with an average target price of $18.40, representing a 74.08% upside. The article also provides expected reven

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 04:09
Source
TradingKey
Finviz Direct company coverage

CARL - Carlsmed Inc Stock Price and Quote

This page provides a detailed financial overview of Carlsmed Inc. (CARL), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists recent news, analyst ratings, and insider trading activity for the company.

Tone
Positive 70/100
Event
Analyst action
Published
01 Jun 2026 22:09
Source
Finviz
TradingView Direct company coverage

Carlsmed, Inc. Cash Flow – LSX:A41CM7

This article provides key cash flow information for Carlsmed, Inc. (LSX:A41CM7), highlighting its free cash flow and operating cash flow figures. For Q1 2026, the company reported a free cash flow of -11.33 million EUR, while for 2025, it was -25.22 million EUR with operating cas

Tone
Neutral 50/100
Event
Balance sheet
Published
28 May 2026 20:39
Source
TradingView
TradingView Direct company coverage

Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7

The article focuses on the price to cash flow ratio of Carlsmed, Inc. (LSX:A41CM7), indicating that this financial metric is accessible via TradingView. It appears to be a stub or a section of a larger financial data platform, providing an overview of where such information can b

Tone
Neutral 50/100
Event
Balance sheet
Published
14 May 2026 07:10
Source
TradingView
TradingView Direct company coverage

Total equity of Carlsmed, Inc. – LSX:A41CM7

The article presents financial information for Carlsmed, Inc. (LSX:A41CM7) on TradingView, specifically focusing on its total equity. It indicates that the market is closed and provides an overview of available financial data. The content is primarily a data display page with var

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 01:09
Source
TradingView
TradingView Direct company coverage

Return on equity % of Carlsmed, Inc. – LSX:A41CM7

This page on TradingView provides financial information for Carlsmed, Inc. (LSX:A41CM7), specifically focusing on its Return on Equity percentage. It presents market data and financial metrics for the company.

Tone
Neutral 50/100
Event
Market update
Published
12 May 2026 21:39
Source
TradingView
TradingView Direct company coverage

Carlsmed, Inc. Income Statement – LSX:A41CM7

This article presents the income statement for Carlsmed, Inc. (LSX:A41CM7), detailing its financial performance. The company reported a total revenue of €13.95 million for the last quarter, an 8.03% increase from the previous quarter, with a net income of -€7.53 million for Q1 20

Tone
Neutral 50/100
Event
Earnings
Published
12 May 2026 15:39
Source
TradingView